Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
August 08, 2024 01:32 ET
|
Recursion Pharmaceuticals
Salt Lake City, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, will provide business updates...
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
August 07, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates
August 07, 2024 07:00 ET
|
Madrigal Pharmaceuticals, Inc.
Second-quarter 2024 net sales of $14.6 million Rezdiffra™ (resmetirom) coverage in place for more than 50 percent of commercial lives; less than 5 percent of Rezdiffra-covered lives require...
Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer
August 07, 2024 02:00 ET
|
Cellectis Inc.
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024 16:05 ET
|
Vaxcyte, Inc.
-- VAX-31 Adult Phase 1/2 Study Topline Safety, Tolerability and Immunogenicity Data Expected in September 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Results, Vaxcyte to Advance VAX-24 or...
Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 06, 2024 16:02 ET
|
Olema Oncology
Presented promising interim clinical results from the ongoing study of palazestrant in combination with ribociclib at the 2024 ESMO Breast Cancer Congress. Updated results expected to be presented at...
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
August 06, 2024 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
August 06, 2024 02:30 ET
|
Abivax
Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC) surpassed the...
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
August 05, 2024 16:01 ET
|
Recursion Pharmaceuticals
Salt Lake City, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
August 02, 2024 16:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024